Author:
Stover Angela M.,McLeod Lori D.,Langer Michelle M.,Chen Wen-Hung,Reeve Bryce B.
Publisher
Springer Science and Business Media LLC
Subject
Health Information Management,Health Informatics
Reference80 articles.
1. U.S. Department of Health and Human Services. (2009). Guidance for industry. Patient-reported outcome measures: Use in medical development to support labeling claims. Bethesda:
http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/UCM193282.pdf
. Accessed Apr 2019.
2. Dinan, M. A., Compton, K. L., Dhillon, J. K., Hammill, B. G., Dewitt, E. M., Weinfurt, K. P., & Schulman, K. A. (2011). Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials. Medical Care, 49(4), 415–419.
3. Kyte, D. G., Draper, H., Ives, J., Liles, C., Gheorghe, A., & Calvert, M. (2013). Patient reported outcomes (PROs) in clinical trials: Is 'in-trial' guidance lacking? A systematic review. PLoS One, 8(4), e60684.
4. Brundage, M., Blazeby, J., Revicki, D., et al. (2013). Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards. Quality of Life Research, 22, 116–1175.
5. Gnanasakthy, A., Mordin, M., & Clark, M. (2012). A review of patient-reported outcome labels in the United States: 2006 to 2010. Value in Health, 15, 437–442.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献